Glucose-lowering therapies and cancer risk: the trials and tribulations of trials and observations

Diabetologia. 2010 Sep;53(9):1823-6. doi: 10.1007/s00125-010-1780-2. Epub 2010 Jun 4.
No abstract available

MeSH terms

  • Clinical Trials as Topic
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / epidemiology
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Hypoglycemic Agents / therapeutic use*
  • Metformin / adverse effects
  • Metformin / therapeutic use
  • Neoplasms / chemically induced*
  • Neoplasms / epidemiology
  • Neoplasms / prevention & control
  • Thiazolidinediones / adverse effects
  • Thiazolidinediones / therapeutic use

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • Metformin